Abstract
BackgroundTabalumab is a human monoclonal antibody that neutralises B-cell activating factor.ObjectivesTo evaluate tabalumab efficacy and safety in patients with rheumatoid arthritis (RA).MethodsThis phase 3, randomised, double-blind, placebo-controlled study evaluated 456...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have